Hearts and Minds Investments (HM1) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
5 Jun, 2025Executive summary
Reported total comprehensive income after tax of $115.3 million for the half year ended 31 December 2024, up from $13.9 million in the prior corresponding period.
Pre-tax investment return, less expenses, was 23.6% for the half year, driven by realised gains and market value increases in Core Portfolio holdings.
Post-tax NTA increased by 16.2% over the half year, prior to the payment of a fully franked dividend of 7.5 cents per share in October 2024.
Share price rose 20% over the half year, with total shareholder return of 23% including dividends.
Philanthropic donations of $4.5 million paid and $5.6 million accrued to medical research organisations during the period.
Financial highlights
Net income for the period was $91.95 million, up from $14.55 million in the prior half year.
Total comprehensive income reached $115.29 million, compared to $13.95 million a year earlier.
Basic and diluted EPS was 40.15 cents, up from 6.36 cents in the prior period.
Pre-tax NTA per share increased from $3.05 to $3.47 after dividend payment, a 13.8% rise.
Share price at 31 December 2024 was $3.10, representing an 11% discount to NTA per share.
Outlook and guidance
Next half-year fully franked dividend of 8.0 cents per share declared, payable on 17 April 2025.
As of 7 February 2025, pre-tax NTA per share was $3.91 and post-tax NTA per share was $3.60.
Latest events from Hearts and Minds Investments
- Flat portfolio returns and a major write-down led to a sharp drop in half-year profit.HM1
H1 202617 Feb 2026 - Strong returns, higher dividends, and active management drive performance and philanthropy.HM1
AGM 20243 Feb 2026 - Strong returns, rising dividends, and major medical research funding highlighted at AGM.HM1
AGM 202526 Nov 2025 - FY25 saw a 25.5% pre-tax return, 24% shareholder return, and $9.5M donated to medical research.HM1
H2 202528 Aug 2025 - Strong investment gains, higher dividends, and robust returns drive improved FY24 results.HM1
H2 202413 Jun 2025